Remdesivir Fails to Benefit COVID-19 Hospitalization, Death in WHO Study

After a series of positive developments, the antiviral agent joins a quartet of candidates that failed to improve severely ill COVID-19 status in the Solidarity study.

Read the full article here

Related Articles